chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case reported by a consumer, describes the occurrence of pyrexia (general fever after the second dose) and headache (little headache after the second dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jul 21, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Aug 18, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pyrexia (general fever after the second dose) and headache (little headache after the second dose). Patient treated with Tylenol (paracetamol) for fever, at an unspecified dose and frequency. At the time of the report, pyrexia (general fever after the second dose) and headache (little headache after the second dose) resolved. No concomitant medication  reported. Treatment information included drinking water for fever. Action taken with mRNA-1273 (Moderna COVID-19 vaccine): not applicable. This case linked to MOD-2021-299977 (patient link).
Patient complaining of site pain, 4 days prior to coming to office. Dr. noted patient to have superficial vesicle at injection site with redness and clear drainage. Culture obtained. Patient put on Cephalexin and awaiting culture results.
About a month after receiving my vaccine, I was diagnosed with anal cancer. I had Non-Hodgkin's lymphoma about seven years ago, but survived. I began chemotherapy in Jun 2022; they did a PEP scan where a lymph node on left groin area that they determined to be malignant. It did not respond to the chemotherapy or radiation treatment. I had to have surgery to remove the lymph node and had another PEP scan following recovery to see if there was any cancerous tissue present still. I recently had a PEP scan on 03/09/2023 and was told the cancer had spread to stage 4 the next morning during my analysis. I feel great, but battle the anxiety not knowing what my future outcome holds.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 06-DEC-2021, the patient was vaccinated with expired dose of Measles, Mumps, and Rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) 0.5 milliliter, lot # reported as S013713 (lot # not valid for Measles, Mumps, and Rubella (wistar RA 27-3) virus vaccine, live (M-M-R II) however is valid for Measles, Mumps, Rubella and Varicella (oka-merck) virus vaccine live (PROQUAD)(albumin status rHA)), expiration date was reported as 04-DEC-2021 (route of administration and anatomical location were not reported) for prophylaxis. No additional adverse event was reported.
Presents to hospital ER on 12/27/21 with his wife with a 5 day history of cough, subjective fevers/chills, diarrhea, body aches, loss of sense of taste and smell, and shortness of breath. Patient received the Johnson and Johnson COVID vaccine on June 15, 2021.  CXR appears to demonstrate rather diffuse atypical pneumonia. Currently on RA however is tachycardic and tachypnic in between sentences.  Received IV dexamethasone and albuterol in the ED.  Was admitted for further management following completion of ED workup. Found to be COVID positive. Started on dexamethasone and remdesivir and IV abx as he required 1L NC.   Patient with improvement and ready to go home 12/29. Walk test, patient not requiring o2 at rest or on exertion. Discharged on 12/29/21
joint pain and stiffness in hands and wrists. Menstral cramps very severe (had never had cramps before) very heavy bleeding 2 weeks after shot. very unusual for her
Pt has redness and swelling on site. Also 101.6 fever. Gave pt doxycycline monohydrate 100 mg 1 capsule BID for 7 days.
Dupuytren's disease of palm. No treatment. Died of other causes 2 months later (date of death 01/05/2022)
This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (her arm is very sore and she can not even raise it) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 012L20A) for COVID-19 vaccination. The patient's past medical history included no adverse event. On Feb 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 17, 2021, patient experienced vaccination site pain (her arm is very sore and she can not even raise it). At the time of the report, vaccination site pain (her arm is very sore and she can not even raise it) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
Administer COVID 19 Moderna Vaccination to patient that was expired on 08/31/2021
Information has been received from a physician concerning a 12 year old female with a history of infectious mononucleosis, who "about two months ago" (approximately in July  2008) was vaccinated with the first dose of GARDASIL, a dose of MENACTRA and another unspecified vaccine. Concomitant therapy included NEURONTIN, ELAVIL, NEXIUM and CLARITIN. The physician stated that "about one week" after receiving vaccination, the patient developed headache, numbness, extremity tingling and pain on the left side of the body. The patient had been unable to attend school for two months because of the adverse symptoms. The patient sought medical attention with an office visit. At time of reporting, the patient had not recovered. Lab tests included a blood work with unknown results. The physician considered the adverse events to be disabling. Additional information has been requested.  12/08/2008 MR received from PCP. Seen 7/14/08 with c/o sore throat, H/A, congestion x 1 week. DX:  Sinusitis-tx abx. Seen in ER 7/15/08 with same sx in addition to joint aches. Thought to be viral etiology. Seen 7/16/08 with additional stomach cramping, body aches, and red bumps on back. Worsening H/A. Worsening pain upper L side.  Feels like throat is swelling up, migratory joint pain. Tx-Tylenol #3. Still c/o joint pain and difficulty sleeping. Assessment:  Joint Pain/Fatigue. ? Viral Syndrome.  By 8/26/08 pt worsening sx-H/A and sensory issues on the L side. Been out of school for long time. Referred to Rheumatology and Neurology.  1/5/09 MR received from Immunology and Neurology consults. 8/19/2008 and 8/26/08. Seen for c/o fatigue, H/A, back pain  and joint pain. Also with c/o numbness of jaw and extremities, episodes of joint swelling, SOB, muscle tightness and nausea which began several days after receiving Gardasil vax. Now in home school due to intensity of sx.  PE (+) for 8/10 H/a, mild (+) Romberg, point tenderness.  Returned 9/16/08 for c/o disturbances of skin sensation.  DX:  Reflex Symphathetic Dystrophy, GER.  Episode 9/18/08 of severe H/A , bilateral arm and leg pain, fever, shaking and vomiting resulting in ER visit.  Assessment: Acute viral illness exacerbating chronic pain d/o.
Shingles; Information has been received from a lawyer referring to a female patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not reported.  In 2017, the patient was vaccinated with Zoster Vaccine Live (ZOSTAVAX) (strength, dose, frequency, route, lot# and expiration date were unknown) for long-term prevention of shingles and zoster-related conditions.   On an unknown date, the patient experienced shingles. The patient did not recover from the event. The patient received treatment. As per the reporter, the patient has and will continue suffer significant medical and related expenses as result of the injury which costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies. The patient was hospitalized due to the event on an unknown date.   The reporter considered the event was related to Zoster Vaccine Live (ZOSTAVAX).
She was given the shot on Tuesday and then Wednesday she took a shower and removed the Band-Aid and started to feel warmth and swelling at the injection site. She used a poison ivy topical spray and started taking oral BENADRYL. Thursday she reported some papules described as hard spots on her back but denies having pustules. Her palms were red as well as having more of the small bumps on her chest and legs. She has been taking ADVIL every 4 hours which is sedating. Yesterday she stop the BENADRYL and had what sounds like a withdrawal headache. She did have some single excoriated papules on her back and upper chest but I did not see any pustules. The right arm injection site has resolved. Diphenhydramine, Hydroxyzine.
Pt had her vaccine at 1550pm and then proceeded to the monitoring area for her 30 minutes of monitoring. At 1620 she complained to the monitoring RN of tongue tingling and a flushed feeling. RN provided pt with diphenhydramine 25mg PO x 1 and water. Pt noted slow and continued improvement of symptoms. Pt monitored longer and discharged to home at 1635.
Headache, fatigue, chills with some shaking, slight nausea, soreness at injection site.  Started in the afternoon and increased until about midnight.  Took a normal ibuprofen dose.  Slept and mostly resolved by morning.  Mild symptoms today (May 4).  Note:  I had minimal symptoms with the first dose; less soreness at the injection site, which came on more gradually.  Reporting this more for data purposes, not as a health problem.
I started experiencing a humming/vibrating sensation in my right ear 2 days post vaccine (4/24).  I saw an ENT on 4/28 and everything looked normal.  Diagnosed with tinnitus and still experiencing it.
My reaction started with itchy eyes.  Then I started experiencing back pain, chills and headache.  On 01/16/2013 I continued to experience chills, fever, headache, fatigue and developed wide spread hives.  On 01/17/2013 I was no longer experiencing chills and fever but the hives and headache continue.  I have extreme sensitivity to touch on my head and abdomen.
tangling in arms and face; blurry vision; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tangling in arms and face) and VISION BLURRED (blurry vision) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) Dose 2. On 24-Feb-2021, the patient experienced PARAESTHESIA (tangling in arms and face) and VISION BLURRED (blurry vision). At the time of the report, PARAESTHESIA (tangling in arms and face) and VISION BLURRED (blurry vision) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment was provided by the reporter. No concomitant medications was provided by the reporter.
Migraine headacche; ADVIL, TYLENOL appears to 6mm.
Beginning 8 days after vaccination: fatigue, unable to do normal activities, decreased appetite, increase in normally well-controlled GERD, muscle and joint pain (much more than my typical connective tissue disease), feeling cold. Still present 6 days after symptoms began,.
Patient noticed follow day that his arm was red, slightly swollen, and pain to the touch. He waited until 05/25/16 and when it still wasn't any better he came in the pharmacy and let us know he was experiencing a reaction. The pharmacist working told him to contact his physician so they could chart his reaction.
Swelling (size of a half dollar per mother), redness the next morning; 4/25/12 increased swelling, problems breathing - EMS transport (family without transportation); antibiotic therapy.  Child admitted to hospital x4 days for IV antibiotic therapy dx: cellulitis.
Endorsed acute chest pain around 1200 on 6/21 initially that seemed to get better. On the early morning of 6/22 at 0400, the pain woke him up from sleep with a 7-8/10 in severity. At this point it was extremely painful for the patient to breathe but he denies shortness of breath. Denies radiation of pain, felt better when he was lying down, worse when sitting up, and was extremely bothersome while ambulating. Presented to Hospital and was found to have elevated troponin ( 7.25--13.00--2.52). Transferred to another Hospital Cardiac MRI supported the diagnosis of myopericarditis. By the time of transfer to Hospital, hos chest pain had resolved. He was treated with a 6 week course of ibuprofen and colchicine.
fever 104, unable to control w/APAP; vomiting adm to hosp;
A week after receiving the first dosis of the Pfizer vaccine and out of a blue, I developed a very high blood pressure, with the highest reading of 216/103. Since the medications to lower the blood pressure my internist gave me were not working properly, I ended up in the Emergency Room of a local hospital a few days later. My doctor thinks this was an immune response of my body to the vaccine. I asked about it the doctors both at the emergency room and also when I receiving the second dosage and they told me they've never heard of high blood pressure related to the Covit vaccine. However, my doctor still thinks it may have been related, especially as I've no history of high blood pressure. Unfortunately, after being vaccinated two months ago, I still suffer from elevated blood pressure.
systemic hives, starting on my back. Fatigue, Body aches, Pain at insertion site, fever 100.8, Low back pain lasting 2 weeks.
1hr p/inject given began having shaking tremors; t103, tachycardia taken to MD to be evaluated approx 12 hrs p/inject screaming & visual distrubances began seeing bugs; 24 hrs post inject pt doing ok; eating & acting nl;
Fever a few hours after varicella, mmr, hep, td, ipv next day client states he broke out in what is seen as fluid filled vesicles on neck, trunk, and back.  Nurse examined, they are yellowish papules, size of acne, all over trunk, back, and neck.
Pt presented to the office, after receiving 2 month immunizations with maculo-papular eruptions on 11/2/01. Suspected adverse reaction. The pt received 4 month immunization on 1/7/02 and again presents with the same type of reaction on 1/9/02. Rash is on both legs and lower abdomen. Unsure of which vaccine may be causing symptoms.
Within weeks of receiving the MMR vaccine in October of her 3rd year, our daughter began having severe colds with lingering cough that she'd never experienced before.  By January, she had what was probably severe bronchitis that never healed up b/c she kept coughing until the next month, when she got bacterial pneumonia with a fever of 105.  She was diagnosed with Reactive Airways Disease and has been on and off Xoponex, Singulair and Pulmacort Respules since then every time she gets even the tiniest cold.  She misses quite a bit of school and outside activities due to this and as she only had a couple of mild colds prior to receiving the MMR vaccine, we feel that it's connected with her exposure to it. My 7 year old daughter still has reactive airways disease 4 years later.
INAPPROPRIATE DOSE OF VACCINE ADMINISTERED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient experienced arm was a little stiff when treated with influenza vaccine for prophylactic vaccination.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 07-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced inappropriate dose of vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of inappropriate dose of vaccine administered was not reported. This report was non-serious.
c/o redness and induration at site of immunization - developed about 12 hrs after vaccine  Arm red, about 3 " X 3" induration and redness over deltoid area LASTED 48 HRS
Deep cough lungs hurt coughed up green colored flem and really bad headache the chills body ached
Legs feel rubbery; Feels weak; Feels like he has the flu; Developed swollen lymph glands the size of a baseball in same arm as injection; Legs Ached; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Legs Ached), LIMB DISCOMFORT (Legs feel rubbery), ASTHENIA (Feels weak), INFLUENZA LIKE ILLNESS (Feels like he has the flu) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (Legs Ached) and HEADACHE (Headache). On an unknown date, the patient experienced LIMB DISCOMFORT (Legs feel rubbery), ASTHENIA (Feels weak), INFLUENZA LIKE ILLNESS (Feels like he has the flu) and VACCINATION SITE LYMPHADENOPATHY (Developed swollen lymph glands the size of a baseball in same arm as injection). On 15-Mar-2021, PAIN IN EXTREMITY (Legs Ached) and HEADACHE (Headache) had resolved. At the time of the report, LIMB DISCOMFORT (Legs feel rubbery), ASTHENIA (Feels weak), INFLUENZA LIKE ILLNESS (Feels like he has the flu) and VACCINATION SITE LYMPHADENOPATHY (Developed swollen lymph glands the size of a baseball in same arm as injection) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications were reported. No treatment information was provided.
Face swelling; dry mouth; dehydration; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: ER2613) via an unspecified route of administration, administered on the left arm on 23Mar2021 13:00 as dose 1, single for COVID-19 immunisation. Medical history included asthma and seasonal allergies. The patient had other medications in two weeks but was not unspecified. The patient previously took amoxicillin sodium;clavulanic acid (AUGMENTIN), levofloxacin (LEVAQUIN), sulfamethoxazole/trimethoprim (BACTRIM), clindamycin, codeine, erythromycin, omeprazole, oxycodone, sulfa and antihistamine and patient experienced allergies. The patient experienced face swelling, dry mouth, dehydration on an unspecified date. The events resulted in Emergency room/department or urgent care visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Therapeutic measures were taken as a result of the events which included steroid injection. Outcome of the events was recovered on an unspecified date.
Pt have fever of 102 with fatigue and body aches. Soreness and sl swelling at injection site - no redness, c/o nausea. Increased fluids, rest, Motrin, Phenergan.
4 yo girl apparently healthy on day of vaccine. Next day went to ER. Life flighted to hospital. Prelim Dx Neisseria Meningococcal. Now lab confirmed.
Pt ok after shots, left HD and 5-10 mins later in car pt grabbed head and said it hurt bad. Mom of pt states pt then laid back in seat, Eyes rolled back and pt started shaking and jerking and she called him name and ask him 2x's are you ok. Pt came to but was cold, clammy and sweating and said he felt numb all over. Mom took pt to ER. Pt had no probs, VS normal. Hospital kept pt 1 1/2 hr and released.
received the second dose three months after the first dose. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose three months after the first dose.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose three months after the first dose.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose three months after the first dose.) outcome was unknown.            No concomitant medications reported by reporter No treatment medications provided by the reporter.   This case was linked to MOD-2021-060921 (Patient Link).
L facial numbness and tingling starting the following day and resolving after 48 hours. 2 weeks later began having twice weekly episodes of palpitations.
Day 1- Nausea, Chills, Diarrhea, Fever, Headache Day 2- Nausea, Chills, Fever, Headache Day 3- Nausea and Headache
This 22 year old female subject was enrolled in a blinded study for the prophylaxis of genital herpes in healthy young females. The subject received IM investigational product singles dose on 3/29/2006 Site of injection was the left deltoid. On 3/29/2006, the subject received the 1st IM injection of blinded study vaccine in the left deltoid. The subject had been randomized to received the active control in this trial, an investigational formulation of Havrix vaccine containing 720 Elisa units of hepatitis A antigen and 500 ug AL OH 3. Lot number DHAVA002A. Medical history the subject reported fatigue and malaise on 29 and 30 March 2006. On April 2/2006, she developed fever 38.89C, more fatigue, malaise, headache and joint pain. These symptoms resolved by 4/10/06. The subject took Yasmin from November 1st to April 2006, ibuprofen from 4/1/06 to 4/3/06 and Tylenol from 4/3/06 to 4/4/06. The subject does not have a history of diabetes, high blood pressure, hyperlipidemia or any other chronic illness. On 4/23/06, 25 days after the 1st dose of Blinded vaccine, this 22 year old subject developed central retinal vein occlusion. Since this day the subject was experiencing episodes of vision loss in her right eye about once a day lasting for up to one hour. On 4/28/06, she consulted an ophthalmologist. Visual acuity at the time of examination was normal. The physician diagnosed central retinal vein occlusion and recommended that she got her blood pressure checked and a fasting blood sugar obtained at the student health center. These test, a chemistry panel and lipid profile were normal on 5/2/06. Testing for lyme disease, mononucleosis and influenza was negative. Blood pressure was 107/73. The subject was taken off her oral contraception and prescribed 1 baby aspirin every day. The last episode of visual symptoms resolved on 4/30/2006. The subjects vision remained normal. This event has been considered to be medically important (OMIC). The vaccination course was stopped ant the subject was withdrawn from the study. The investigator considered that there was a reasonable possibility that the central retinal vein occlusion may have been caused by investigational product due to the temporal association between the last vaccine dose administration and the onset of the event and he also considered Yasmin (Contraception) as an other possible cause for the SAE.
afebriel; NAD; active ambulating, t97.5; general fine pruritic papular rash; otherwise PE WNL;